Improved Solutions for Rare Diseases.

Dipharma SA is a Swiss pharmaceutical company specialized in

developing generic high quality medicines for rare diseases.

Dipharma SA is part of the Dipharma Group, a third generation family company founded in 1949 and grown to a global presence. Our goal is to improve the quality of life of patients affected with rare diseases, providing them with high quality medicines at an affordable cost.
First Regulatory Submission in USA An Abbreviated New Drug Application has been submitted to the FDA for Miglustat 100mg Capsules [read more] First Marketing Authorization DiterinTM (Sapropterin Dihydro- chloride 100mg tablets) obtains its first marketing authorization on 27 October 2015 New Headquarter New Headquarter Office in Chiasso inaugurated on 18 September 2015